Client Result
Orrick berät US-Software-Investor Turn/River Capital bei strategischer Investition in die Paessler AG
2 minute read | May.28.2024

2 minute read | May.28.2024
by Zac Padgett, Daniel Lopez, Richard Smith and Nnaemeka K. Anyanwu
5 minute read | May.22.2023
1 minute read | January.11.2023
August.02.2022
June.27.2022
The primary focus of the acquisition is on the lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor.
January.25.2022
January.20.2022
Orrick has advised Ford Next in the creation of Canopy, a joint venture with ADT Inc.
December.20.2021
October.20.2021
Orrick has advised Turn/River Capital on its investment in Invicti Security’s $625 million funding round, led by Summit Partners.
July.15.2021
January.22.2021
January.08.2021